http://ec.europa.eu/research/brainmonth2013
Within the Month of the Brain, two major conferences are planned for 14 May (Brussels, Belgium) and 27&28 May (Dublin, Ireland).
14 May 2013 (Brussels, Belgium): This first conference will be dedicated to “European Brain Research: Successes and Next Challenges”
This conference will
(i) showcase and raise awareness about the benefits, added value and impact of brain research and healthcare in this critical period of financial austerity;
(ii) outline and discuss the future and emerging scientific needs in brain research and healthcare. This event will therefore not only provide an opportunity to learn more about successful EU-supported projects but will also constitute a platform to contribute to Horizon 2020, the new EU programme for supporting research and innovation.
To this end, the conference will see the participation of leaders in brain research and healthcare from around the globe, including industry and patient representatives, scientists and policymakers. In addition to individual talks, there will be opportunities for discussion to which everybody present will be welcome to contribute. The conference will be open to the general public and free of charge.
27 & 28 May 2013 (Dublin, Ireland): This two-day conference will de dedicated to “Healthy Brain – Healthy Europe: a new horizon for brain research and health care” and will see the participation of the health ministrers of the 27 Member States.
Prof. R. Hughes has been invited to chair the session dedicated to “The brain challenge”.
This conference will focus on future policy in the area of brain research and healthcare and will be targeted at policy-makers. The conference’s objectives will be (i) to reinforce coordination and optimization of resources in brain research and healthcare; (ii) to develop European and national brain research and healthcare strategies; (iii) to lift taboos associated with brain health issues.
It will engage international leaders in brain research and healthcare from around the globe, in particular European and national governmental representatives, funding agencies, capital venture, industry, scientists, research organisations, patient organisations, clinicians, representatives of national health care systems.
The conference is restricted to 400 invited participants.
EBC will be involved and will take part in both conferences.
